Zhejiang Anglikang Pharmaceutical Co Ltd Class A (002940) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.062x

Based on the latest financial reports, Zhejiang Anglikang Pharmaceutical Co Ltd Class A (002940) has a cash flow conversion efficiency ratio of 0.062x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥112.57 Million ≈ $16.47 Million USD) by net assets (CN¥1.83 Billion ≈ $267.16 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Zhejiang Anglikang Pharmaceutical Co Ltd (002940) balance sheet quality index to measure how much of total assets are equity-financed.

Zhejiang Anglikang Pharmaceutical Co Ltd Class A - Cash Flow Conversion Efficiency Trend (2014–2025)

This chart illustrates how Zhejiang Anglikang Pharmaceutical Co Ltd Class A's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check 002940 operating cash flow to net income to evaluate the quality of earnings relative to operating cash generation.

Zhejiang Anglikang Pharmaceutical Co Ltd Class A Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Zhejiang Anglikang Pharmaceutical Co Ltd Class A ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
B Communications Ltd TA:BCOM	0.170x
Shanghai Hugong Elec(Group) SHG:603131	0.000x
Cheng Loong Corp TW:1904	0.055x
Guangdong Biolight Meditech Co Ltd SHE:300246	0.052x
Changchun Engley Automobile Industry Co.Ltd. SHG:601279	0.024x
Iperionx Ltd AU:IPX	0.000x
Shinyoung Securities Co. Ltd. KO:001720	-0.156x
ORIENT SECUR.CO.LTD.H YC1 F:OS9	0.133x

Annual Cash Flow Conversion Efficiency for Zhejiang Anglikang Pharmaceutical Co Ltd Class A (2014–2025)

The table below shows the annual cash flow conversion efficiency of Zhejiang Anglikang Pharmaceutical Co Ltd Class A from 2014 to 2025. For the full company profile with market capitalisation and key ratios, see Zhejiang Anglikang Pharmaceutical Co Ltd market capitalisation.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	CN¥1.87 Billion ≈ $273.23 Million	CN¥244.13 Million ≈ $35.72 Million	0.131x	-7.28%
2024-12-31	CN¥1.80 Billion ≈ $263.17 Million	CN¥253.60 Million ≈ $37.11 Million	0.141x	-6.69%
2023-12-31	CN¥1.83 Billion ≈ $268.12 Million	CN¥276.91 Million ≈ $40.52 Million	0.151x	+34.66%
2022-12-31	CN¥1.65 Billion ≈ $240.88 Million	CN¥184.75 Million ≈ $27.03 Million	0.112x	-16.25%
2021-12-31	CN¥1.47 Billion ≈ $215.83 Million	CN¥197.65 Million ≈ $28.92 Million	0.134x	-7.03%
2020-12-31	CN¥1.38 Billion ≈ $201.64 Million	CN¥198.61 Million ≈ $29.06 Million	0.144x	-31.38%
2019-12-31	CN¥1.02 Billion ≈ $148.74 Million	CN¥213.49 Million ≈ $31.24 Million	0.210x	+52.63%
2018-12-31	CN¥970.93 Million ≈ $142.08 Million	CN¥133.61 Million ≈ $19.55 Million	0.138x	-71.99%
2017-12-31	CN¥394.37 Million ≈ $57.71 Million	CN¥193.77 Million ≈ $28.36 Million	0.491x	+13.50%
2016-12-31	CN¥327.43 Million ≈ $47.91 Million	CN¥141.74 Million ≈ $20.74 Million	0.433x	-17.47%
2015-12-31	CN¥264.20 Million ≈ $38.66 Million	CN¥138.59 Million ≈ $20.28 Million	0.525x	+125.68%
2014-12-31	CN¥217.08 Million ≈ $31.77 Million	CN¥50.46 Million ≈ $7.38 Million	0.232x	--

About Zhejiang Anglikang Pharmaceutical Co Ltd Class A

SHE:002940 China Drug Manufacturers - Specialty & Generic

Market Cap

$745.06 Million

CN¥5.09 Billion CNY

Market Cap Rank

#10153 Global

#2659 in China

Share Price

CN¥25.24

Change (1 day)

+2.39%

52-Week Range

CN¥23.41 - CN¥58.08

All Time High

CN¥249286.54